PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation Journal Articles Refereed uri icon

Overview

Published in

  • Molecular Cancer

Time

Date/time value

  • 2017

Identity

Digital Object Identifier (DOI)

  • 10.1186/s12943-017-0684-x

Additional Document Info

Parent Title

  • MOLECULAR CANCER

Volume

  • 16

Number

  • ARTN 112

Publisher

  • Biomed Central